Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
05.12.2023 14:01:57
|
Eli Lilly Announces Availability Of Zepbound In U.S. Pharmacies - Quick Facts
(RTTNews) - Eli Lilly and Company (LLY) announced that Zepbound injection is now available. It is indicated for adults with obesity, or those who are overweight and also have weight-related medical problems. The company said, following the FDA approval, people living with obesity can now access Zepbound in six doses through a prescription.
Effective Dec. 1, 2023, Zepbound was added to the National Preferred Formulary for Express Scripts and Cigna Healthcare. Effective Dec. 15, 2023, it will be added to Cigna Healthcare's commercial formularies.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 715,30 | 2,07% |
|